688505 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.
- 6.75
- +0.07+1.05%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. News
Fudan Zhangjiang Announcement on Participating in the 2024 Semi-Annual Pharmaceutical and Biological Products Special Group Performance Briefing
Announcement of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.'s special report on the use and placement of fundraising during the first half of 2024.
Announcement of the Resolution of the Sixth Meeting of the Eighth Supervisory Committee of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.
Mid-year evaluation report of the 'Improving Efficiency and Returning More' action plan for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. in 2024.
Announcement from Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. regarding the 2024 interim performance presentation.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. announcement listed in Hong Kong.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. announcement listed in Hong Kong.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. announcement listed in Hong Kong.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. announcement listed in Hong Kong.
Announcement on the cancellation of part of the raised funds special account by Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.
Rules of the Fudan-Zhangjiang Supervisory Board Meeting
Rules of the Shareholders Meeting of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.'s Articles of Association.
Legal Opinion Letter of Shanghai Fangda Law Firm on the Annual Shareholders' Meeting of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. in 2023.
Announcement of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. regarding government subsidies received.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. announcement listed in Hong Kong.
Announcement of Resolutions of the Fifth Meeting of the Eighth Board of Supervisors of Fudan Zhangjiang
Announcement of Fudan and Zhangjiang on the use of temporarily idle funds raised for cash management
Inspection opinions of Haitong Securities Co., Ltd. on the use of temporarily idle funds raised by Shanghai Fudan Zhangjiang Biomedical Co., Ltd. for cash management
Inspection opinions of Haitong Securities Co., Ltd. on the information disclosure regulatory inquiry letter on the 2023 annual report of Shanghai Fudan Zhangjiang Biomedical Co., Ltd.
Analysis
Price Target
No Data
